They concluded that while the EC plays a central role in the early appearance of tau, it may be that the inferior temporal cortex is the critical region for rapid tau accumulation in preclinical AD, a finding that may play a significant role in improving the selection of participants for preventive trials. Here, MAPT is linked to Alzheimer disease.